Product Description
Adoption is expected to continue over the forecast period, but unit sales will continue exhibiting negative growth, due to the long lifespan of virtual colonoscopy software. One positive factor that might help counter unit erosion is the relative affordability of colonography against optical colonoscopy. Given the growing costs of colonoscopy screening in the United States, the market might turn its attention back to colonography.
Virtual colonoscopy is a procedure used for screening the large intestine for any polyps (abnormal growths), colorectal cancer, and other diseases or defects. Unlike a regular colonoscopy, this procedure is non-invasive. Before the examination begins, a tube is inserted into the rectum to inflate the colon with air. This makes the colon larger and the surface area less convoluted, allowing for a clearer and more thorough examination. A laxative and a tagging agent are ingested by the patient prior to the procedure in order to reduce the amount of fecal matter in the colon and make the remainder easily distinguishable. Virtual colonoscopy does not require the use of a sedative, thus eliminating side-effect risks as well as allowing patients to return to their normal activities immediately following the procedure.
Segments Covered in This Market
- Virtual Colonoscopy Software Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the many companies in the U.S. Virtual Colonoscopy Software market, GE Healthcare was the leader, followed by Siemens and Vital Images. GE leverages its strong position in those markets to sell its virtual colonoscopy products, often bundling its software with its imaging devices. The company currently offers the Advantage 4D product line. Other companies analyzed include Philips, Viatronix, and TeraRecon.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis of a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled U.S. Market Report Suite for Gastrointestinal Endoscopic Devices – MedSuite
